This publication is intended as an educational resource for New Zealand health professionals managing patients with chronic kidney disease (CKD) with comorbid type 2 diabetes. The focus of this publication is the importance of guideline-directed medical therapy (GDMT) for CKD in diabetes, in particular looking at the four pillars of therapy. This review is supported by an independent educational grant from Boehringer Ingelheim and Eli Lilly.
Please login below to download this issue (PDF)